• 35601 Citations
  • 102 h-Index
1978 …2023
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Keith Lindor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Sclerosing Cholangitis Medicine & Life Sciences
Biliary Liver Cirrhosis Medicine & Life Sciences
Ursodeoxycholic Acid Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Liver Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cholangitis Medicine & Life Sciences
Fibrosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

Sclerosing Cholangitis
Cholangiocarcinoma
Practice Guidelines
Gallbladder Neoplasms
Neoplasms
1 Citation (Scopus)

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Early Detection of Cancer
Cholangiocarcinoma
Neoplasms
Inflammatory Bowel Diseases
3 Citations (Scopus)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., Feb 14 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Epidemiology
Neoplasms
End Stage Liver Disease
Cholangiocarcinoma
1 Citation (Scopus)

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Registries
Demography
Patient Reported Outcome Measures
Databases

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease

Palmer, M., Regev, A., Lindor, K., Avigan, M. I., Dimick-Santos, L., Treem, W., Marcinak, J. F., Lewis, J. H., Anania, F. A., Seekins, D., Shneider, B. L. & Chalasani, N., Jan 1 2019, (Accepted/In press) In : Alimentary Pharmacology and Therapeutics.

Research output: Contribution to journalReview article

Open Access
Chemical and Drug Induced Liver Injury
Practice Guidelines
Liver Diseases
Clinical Trials
Guidelines

Projects 2012 2023